357 related articles for article (PubMed ID: 24164400)
1. Redo living-donor lobar lung transplantation for bronchiolitis obliterans associated with antibody-mediated rejection.
Chen F; Miyagawa-Hayashino A; Yurugi K; Chibana N; Yamada T; Sato M; Aoyama A; Takakura S; Bando T; Date H
Transpl Int; 2014 Feb; 27(2):e8-12. PubMed ID: 24164400
[TBL] [Abstract][Full Text] [Related]
2. [Retransplantation after Bilateral Living-donor Lobar Lung Transplantation].
Chen-Yoshikawa TF; Date H
Kyobu Geka; 2021 Sep; 74(10):850-855. PubMed ID: 34548458
[TBL] [Abstract][Full Text] [Related]
3. Living-donor lobar lung transplantation for bronchiolitis obliterans after bone marrow transplantation.
Sano Y; Date H; Nagahiro I; Aoe M; Shimizu N
Ann Thorac Surg; 2005 Mar; 79(3):1051-2. PubMed ID: 15734441
[TBL] [Abstract][Full Text] [Related]
4. Living donor lobar lung transplantation: the pediatric experience.
Woo MS; MacLaughlin EF; Horn MV; Wong PC; Rowland JM; Barr ML; Starnes VA
Pediatr Transplant; 1998 Aug; 2(3):185-90. PubMed ID: 10084740
[TBL] [Abstract][Full Text] [Related]
5. Donor-specific antibodies are associated with antibody-mediated rejection, acute cellular rejection, bronchiolitis obliterans syndrome, and cystic fibrosis after lung transplantation.
Lobo LJ; Aris RM; Schmitz J; Neuringer IP
J Heart Lung Transplant; 2013 Jan; 32(1):70-7. PubMed ID: 23260706
[TBL] [Abstract][Full Text] [Related]
6. Living lobar lung transplantation.
Bowdish ME; Barr ML
Respir Care Clin N Am; 2004 Dec; 10(4):563-79. PubMed ID: 15585183
[TBL] [Abstract][Full Text] [Related]
7. Long-term improvement in pulmonary function after living donor lobar lung transplantation.
Yamane M; Date H; Okazaki M; Toyooka S; Aoe M; Sano Y
J Heart Lung Transplant; 2007 Jul; 26(7):687-92. PubMed ID: 17613398
[TBL] [Abstract][Full Text] [Related]
8. Update on living-donor lobar lung transplantation.
Date H
Curr Opin Organ Transplant; 2011 Oct; 16(5):453-7. PubMed ID: 21836512
[TBL] [Abstract][Full Text] [Related]
9. Effect of development of antibodies to HLA and cytomegalovirus mismatch on lung transplantation survival and development of bronchiolitis obliterans syndrome.
Smith MA; Sundaresan S; Mohanakumar T; Trulock EP; Lynch JP; Phelan DL; Cooper JD; Patterson GA
J Thorac Cardiovasc Surg; 1998 Nov; 116(5):812-20. PubMed ID: 9806388
[TBL] [Abstract][Full Text] [Related]
10. Living-donor lobar lung transplantation for broncho-bronchiolitis obliterans after allogeneic hematopoietic stem cell transplantation: does bronchiolitis obliterans recur in transplanted lungs?
Okumura H; Ohtake S; Ontachi Y; Ozaki J; Shimadoi S; Waseda Y; Kondo Y; Yamazaki H; Takami A; Yasui M; Date H; Nakao S
Int J Hematol; 2007 Nov; 86(4):369-73. PubMed ID: 18055347
[TBL] [Abstract][Full Text] [Related]
11. Assessment of mean transit time in the engrafted lung with 133Xe lung ventilation scintigraphy improves diagnosis of bronchiolitis obliterans syndrome in living-donor lobar lung transplant recipients.
Shinya T; Sato S; Kato K; Gobara H; Akaki S; Date H; Kanazawa S
Ann Nucl Med; 2008 Jan; 22(1):31-9. PubMed ID: 18250985
[TBL] [Abstract][Full Text] [Related]
12. Living donor lobar grafts improve pediatric lung retransplantation survival.
Kozower BD; Sweet SC; de la Morena M; Schuler P; Guthrie TJ; Patterson GA; Gandhi SK; Huddleston CB
J Thorac Cardiovasc Surg; 2006 May; 131(5):1142-7. PubMed ID: 16678602
[TBL] [Abstract][Full Text] [Related]
13. Antibody-mediated rejection of a unilateral donor lung in bilateral living-donor lobar lung transplantation: report of a case.
Chen F; Chibana N; Kanematsu A; Takakura S; Yurugi K; Hishida R; Fukatsu A; Kubo T; Shoji T; Fujinaga T; Bando T; Date H
Surg Today; 2012 Aug; 42(8):808-11. PubMed ID: 22370964
[TBL] [Abstract][Full Text] [Related]
14. Unilateral humoral rejection after reoperative single-lung transplant.
Beaty CA; Yang A; George TJ; Illei PB; Shah AS
Ann Thorac Surg; 2013 Apr; 95(4):e79-81. PubMed ID: 23522237
[TBL] [Abstract][Full Text] [Related]
15. Long-term outcomes of living-donor lobar lung transplantation.
Sugimoto S; Date H; Miyoshi K; Otani S; Ishihara M; Yamane M; Toyooka S
J Thorac Cardiovasc Surg; 2022 Aug; 164(2):440-448. PubMed ID: 34895720
[TBL] [Abstract][Full Text] [Related]
16. Pediatric living donor lobar lung transplantation.
Sweet SC
Pediatr Transplant; 2006 Nov; 10(7):861-8. PubMed ID: 17032437
[TBL] [Abstract][Full Text] [Related]
17. Long-term outcome after pulmonary retransplantation.
Strueber M; Fischer S; Gottlieb J; Simon AR; Goerler H; Gohrbandt B; Welte T; Haverich A
J Thorac Cardiovasc Surg; 2006 Aug; 132(2):407-12. PubMed ID: 16872970
[TBL] [Abstract][Full Text] [Related]
18. HLA mismatches influence lung transplant recipient survival, bronchiolitis obliterans and rejection: implications for donor lung allocation.
Peltz M; Edwards LB; Jessen ME; Torres F; Meyer DM
J Heart Lung Transplant; 2011 Apr; 30(4):426-34. PubMed ID: 21145259
[TBL] [Abstract][Full Text] [Related]
19. Acquired recipient pulmonary function is better than lost donor pulmonary function in living-donor lobar lung transplantation.
Kayawake H; Chen-Yoshikawa TF; Hamaji M; Nakajima D; Ohsumi A; Aoyama A; Date H
J Thorac Cardiovasc Surg; 2019 Dec; 158(6):1710-1716.e2. PubMed ID: 31399240
[TBL] [Abstract][Full Text] [Related]
20. How to predict forced vital capacity after living-donor lobar-lung transplantation.
Date H; Aoe M; Nagahiro I; Sano Y; Matsubara H; Goto K; Kawada M; Shimizu N
J Heart Lung Transplant; 2004 May; 23(5):547-51. PubMed ID: 15135369
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
